NCT00453310 · OUTCOME

Confirmed Objective Response Rate (Complete and Partial Response) as Measured by RECIST Criteria After 2 Courses of Treatment

Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment · Source last updated 2015-10-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: participants
Interval / dispersion: Not reported
Time frame: 2 years

Groups in this outcome

Sunitinib Malate

The dose of sunitinib malate will be a continuous daily dose of 37.5 mg administered orally for 6 weeks. The cycle of therapy is 42 days (or 6 weeks) sunitinib malate

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Sunitinib Malate	10

Reported measurements

Stable Disease

Values in participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Sunitinib Malate	3	Not reported	Not reported	Not reported	Not reported

Progression of Disease

Values in participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Sunitinib Malate	7	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
3
title
Stable Disease
categories
measurements
group Id
OG000
value
7
title
Progression of Disease

denoms

counts
group Id
OG000
value
10
units
Participants

groups

description
The dose of sunitinib malate will be a continuous daily dose of 37.5 mg administered orally for 6 weeks. The cycle of therapy is 42 days (or 6 weeks) sunitinib malate
id
OG000
title
Sunitinib Malate

param Type

NUMBER

reporting Status

POSTED

time Frame

2 years

title

Confirmed Objective Response Rate (Complete and Partial Response) as Measured by RECIST Criteria After 2 Courses of Treatment

type

PRIMARY

unit Of Measure

participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice